© 1999 American Heart Association, Inc.
Cellular Biology |
Human Activin-A Is Expressed in the Atherosclerotic Lesion and Promotes the Contractile Phenotype of Smooth Muscle Cells
From the Academic Medical Center (M.A.E., J.M.N., T.A.E.v.A., B.E.v.A., H.P., C.J.M.d.V.), University of Amsterdam, Department of Biochemistry, Amsterdam and Erasmus University (R.H.N.v.S.), Department of Endocrinology and Reproduction, Rotterdam, The Netherlands.
Correspondence to Carlie J.M. de Vries, PhD, Department of Biochemistry, Academic Medical Center K1-163, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands. E-mail c.j.devries{at}amc.uva.nl
Abstract—Activin is a member of
the transforming growth factor-ß superfamily, and it modulates the
proliferation and differentiation of various target cells. In this
study, we investigated the role of activin in the initiation and
progression of human atherosclerosis. The expression of
activin, its physiological inhibitor
follistatin, and activin receptors were assayed in human vascular
tissue specimens that represented various stages of
atherogenesis. In situ hybridization experiments revealed activin mRNA
in endothelial cells and macrophages and a
strong induction of activin expression in neointimal smooth
muscle cells from the early onset of atherogenesis. We developed an
"in situ free-activin binding assay" by using biotinylated
follistatin, which allowed us to detect bioactive activin at specific
sites in atherosclerotic lesions. The mRNAs encoding the activin
receptors are expressed similarly in normal and atherosclerotic tissue,
which indicates that activin-A signaling in atherogenesis is most
likely dependent on changes in growth factor concentrations rather than
on receptor levels. In vitro, activin induces the contractile,
nonproliferative phenotype in cultured smooth muscle cells, as
is reflected by increased expression of smooth muscle-specific markers
(SM
-actin and SM22). Our data provide evidence that
activin induces redifferentiation of neointimal smooth
muscle cells, and we hypothesize that activin is involved in
plaque stabilization.
Key Words: atherosclerosis • smooth muscle cell • follistatin • transforming growth factor-ß
This article has been cited by other articles:
 |
|
 |
|
  G. T.L. Kloppenburg, G. E. Grauls, C. A. Bruggeman, and F. R. Stassen Adenoviral activin A expression prevents vein graft intimal hyperplasia in a rat model Interactive CardioVascular and Thoracic Surgery, January 1, 2009; 8(1): 31 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Eijken, S. Swagemakers, M. Koedam, C. Steenbergen, P. Derkx, A. G. Uitterlinden, P. J. van der Spek, J. A. Visser, F. H. de Jong, H. A. P. Pols, et al. The activin A-follistatin system: potent regulator of human extracellular matrix mineralization FASEB J, September 1, 2007; 21(11): 2949 - 2960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tedgui and Z. Mallat Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways Physiol Rev, April 1, 2006; 86(2): 515 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kobayashi, K. Yokote, M. Fujimoto, K. Yamashita, A. Sakamoto, M. Kitahara, H. Kawamura, Y. Maezawa, S. Asaumi, T. Tokuhisa, et al. Targeted Disruption of TGF-{beta}-Smad3 Signaling Leads to Enhanced Neointimal Hyperplasia With Diminished Matrix Deposition in Response to Vascular Injury Circ. Res., April 29, 2005; 96(8): 904 - 912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Wang, X. Zhu, Q. Xu, X. Ding, Y. E. Chen, and Q. Song Effect of C-reactive protein on gene expression in vascular endothelial cells Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1539 - H1545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Spin, S. Nallamshetty, R. Tabibiazar, E. A. Ashley, J. Y. King, M. Chen, P. S. Tsao, and T. Quertermous Transcriptional profiling of in vitro smooth muscle cell differentiation identifies specific patterns of gene and pathway activation Physiol Genomics, November 17, 2004; 19(3): 292 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Smith, A. Yndestad, B. Halvorsen, T. Ueland, T. Waehre, K. Otterdal, H. Scholz, K. Endresen, L. Gullestad, S. S. Froland, et al. Potential anti-inflammatory role of activin A in acute coronary syndromes J. Am. Coll. Cardiol., July 21, 2004; 44(2): 369 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Yndestad, T. Ueland, E. Oie, G. Florholmen, B. Halvorsen, H. Attramadal, S. Simonsen, S. S. Froland, L. Gullestad, G. Christensen, et al. Elevated Levels of Activin A in Heart Failure: Potential Role in Myocardial Remodeling Circulation, March 23, 2004; 109(11): 1379 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Grainger Transforming Growth Factor {beta} and Atherosclerosis: So Far, So Good for the Protective Cytokine Hypothesis Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 399 - 404. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. E. King, V. P. Iyemere, P. L. Weissberg, and C. M. Shanahan Kruppel-like Factor 4 (KLF4/GKLF) Is a Target of Bone Morphogenetic Proteins and Transforming Growth Factor beta 1 in the Regulation of Vascular Smooth Muscle Cell Phenotype J. Biol. Chem., March 21, 2003; 278(13): 11661 - 11669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. de Waard, T. A.E. van Achterberg, N. J. Beauchamp, H. Pannekoek, and C. J.M. de Vries Cardiac Ankyrin Repeat Protein (CARP) Expression in Human and Murine Atherosclerotic Lesions: Activin Induces Carp in Smooth Muscle Cells Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): 64 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Engelse, J. H.P. Lardenoye, J. M. Neele, J. M. Grimbergen, M. R. de Vries, M. L.M. Lamfers, H. Pannekoek, P. H.A. Quax, and C. J.M. de Vries Adenoviral Activin A Expression Prevents Intimal Hyperplasia in Human and Murine Blood Vessels by Maintaining the Contractile Smooth Muscle Cell Phenotype Circ. Res., May 31, 2002; 90(10): 1128 - 1134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. Berk Vascular Smooth Muscle Growth: Autocrine Growth Mechanisms Physiol Rev, July 1, 2001; 81(3): 999 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. Coombes and J. B. Mahony cDNA Array Analysis of Altered Gene Expression in Human Endothelial Cells in Response to Chlamydia pneumoniae Infection Infect. Immun., March 1, 2001; 69(3): 1420 - 1427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. I Axel, A. Frigge, J. Dittmann, H. Runge, I. Spyridopoulos, R. Riessen, R. Viebahn, and K. R Karsch All-trans retinoic acid regulates proliferation, migration, differentiation, and extracellular matrix turnover of human arterial smooth muscle cells Cardiovasc Res, March 1, 2001; 49(4): 851 - 862. [Abstract] [Full Text] [PDF]
|
|